Pluristem Therapeutics, a placenta-based cell therapy development company, has announced the results of pre-clinical trials examining PLX cells as a treatment for collagenase-induced patellar tendon injuries in rats.
The trials were led by Scott Rodeo, MD, at the Hospital for Special Surgery in New York. Dr. Rodeo serves as the co-chief of sports medicine and shoulder service at Hospital for Special Surgery and a professor of orthopedic surgery at Weill Cornell Medical College in New York.
The pre-clinical trials found evidence that PLX cells are a promising treatment for tendon and other orthopedic injuries.
More Articles on Sports Medicine:
Dr. Naven Duggal Joins Syracuse Orthopedic Specialists
9 Statistics on Orthopedic Surgeon Occupational Injury
Drs. Chad Price, Colin Crosby Join Elite Sports Medicine in Nashville